Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study
Authors:
- Cristina Lasarte-MonterrubioCLCristina Lasarte-Monterrubio
- Paula Guijarro-SánchezPGPaula Guijarro-Sánchez
- Isaac Alonso-GarciaIAIsaac Alonso-Garcia
- Michelle OutedaMOMichelle Outeda
- Lucia González-PintoLGLucia González-Pinto
- Marta Martínez-GuitiánMarta Martínez-Guitián
- Carlos Fernández-LozanoCarlos Fernández-Lozano
- Juan Carlos Vázquez-UchaJuan Carlos Vázquez-Ucha
- Jorge Arca-SuárezJAJorge Arca-Suárez
- Alejandro BeceiroABAlejandro Beceiro
Open Access
- 11 April 2024
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 29 (15) , 2300352
Abstract
Background: As increasing antibiotic resistance in Acinetobacter baumannii poses a global healthcare challenge, understanding its evolution is crucial for effective control strategies. Aim: We aimed to evaluate the epidemiology, antimicrobial susceptibility and main resistance mechanisms of Acinetobacter spp. in Spain in 2020, and to explore temporal trends of A. baumannii. Methods: We collected 199 single-patient Acinetobacter spp. clinical isolates in 2020 from 18 Spanish tertiary hospitals. Minimum inhibitory concentrations (MICs) for nine antimicrobials were determined. Short-read sequencing was performed for all isolates, and targeted long-read sequencing for A. baumannii. Resistance mechanisms, phylogenetics and clonality were assessed. Findings on resistance rates and infection types were compared with data from 2000 and 2010. Results: Cefiderocol and colistin exhibited the highest activity against A. baumannii, although colistin susceptibility has significantly declined over 2 decades. A. non-baumannii strains were highly susceptible to most tested antibiotics. Of the A. baumannii isolates, 47.5% (56/118) were multidrug-resistant (MDR). Phylogeny and clonal relationship analysis of A. baumannii revealed five prevalent international clones, notably IC2 (ST2, n = 52; ST745, n = 4) and IC1 (ST1, n = 14), and some episodes of clonal dissemination. Genes bla OXA-23, bla OXA-58 and bla OXA-24/40 were identified in 49 (41.5%), eight (6.8%) and one (0.8%) A. baumannii isolates, respectively. ISAba1 was found upstream of the gene (a bla OXA-51-like) in 10 isolates. Conclusions: The emergence of OXA-23-producing ST1 and ST2, the predominant MDR lineages, shows a pivotal shift in carbapenem-resistant A. baumannii (CRAB) epidemiology in Spain. Coupled with increased colistin resistance, these changes underscore notable alterations in regional antimicrobial resistance dynamics.Keywords
This publication has 36 references indexed in Scilit:
- The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem‐resistant Acinetobacter baumannii isolates in Germany, 2010‐2019International Journal of Antimicrobial Agents, 2022
- OXA-23 and OXA-40 producing carbapenem-resistant Acinetobacter baumannii in Central IllinoisDiagnostic Microbiology and Infectious Disease, 2020
- Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibioticsInternational Journal of Antimicrobial Agents, 2020
- Predominance of international clone 2 OXA-23-producing- Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide studyInternational Journal of Antimicrobial Agents, 2017
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)Enfermedades Infecciosas y Microbiología Clínica, 2013
- Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineagesInternational Journal of Antimicrobial Agents, 2013
- Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in TaiwanInternational Journal of Antimicrobial Agents, 2010
- Clinical Features and Epidemiology of Acinetobacter baumannii Colonization and Infection in Spanish HospitalsInfection Control, 2004
- Diversidad clonal y sensibilidad a los antimicrobianos de Acinetobacter baumannii aislados en hospitales españoles. Estudio multicéntrico nacional: proyecto GEIH-Ab 2000Enfermedades Infecciosas y Microbiología Clínica, 2004